Controlled release 

Our in-depth expertise in this area is available for parties interested in custom development of bioresorbable controlled release systems.

We are highly commited to create the best solution for our customers. Those customers seeking for breakthrough technologies we can bring in expertise of and access to unique polymer systems:

• Ester homopolymers and copolymers (e.g. PLA, PLGA, PCL)
• Ester block copolymers (SynBiosys)
• Ether-ester block copolymers (SynBiosys, PolyActive, InGell)
• Orthoester copolymers

InGell: InGell polymers are bioresorbable phase transfer polymers that form self assembling aqueous gels after injection in vivo. Pharmaceutical product development using InGell polymers is offered through our new partner and subsidiary InGell Labs. 

SynBiosys: By our partner and subsidiary InnoCore Technologies we capitalize a proprietary family of bioresorbable multi-block copolymers for medical and pharmaceutical controlled release systems with focus on medical device coatings, microspheres and injectable solid implants. Please visit www.innocorepharma.com for additional information on development and licensing opportunities.

PolyActive: OctoPlus is holding rights on applying PolyActive for pharmaceutical drug delivery systems. Please visit www.octoplus.nl to learn more.